| Overview |
| bsm-30093M-PE-Cy5 |
| CD4 (HIT4a) Monoclonal Antibody, PE-Cy5 Conjugated |
| FCM |
| Human |
| Specifications |
| PE-Cy5 |
| Mouse |
| KLH conjugated synthetic peptide derived from human CD4 |
| Monoclonal |
| HIT4a |
| IgG2b |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20¡C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 920 |
| P01730 |
| Cell membrane |
| CD4 Molecule; T-Cell Surface Glycoprotein CD4; T-Cell Surface Antigen T4/Leu-3; CD4 Antigen (P55); CD4 Receptor; CD4 Antigen; CD4mut; |
This gene encodes a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility complex class II antigenes and is also a receptor for the human immunodeficiency virus. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, and granulocytes. It is also expressed in specific regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Aug 2010].
|
| Application Dilution |
| FCM |
1:20-100 |
Powered by Bioz